Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tweet2Quit for Tobacco Addiction
NCT02823028Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Oct 2016
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Tobacco Use Disorder (TUD) (4 arms), sponsored by University of California, Irvine. Primary endpoint: Percentage of Participants With a 6-month Sustained Abstinence. Started Oct 2016; status: completed.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02823028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823028.